Intracisternal injection of inflammatory soup activates the trigeminal nerve system

Cephalalgia

Volumn 29, Issue 11, 2009, Pages 1212-1217

  Hoffmann, J ^a   Neeb, L ^a   Israel, H ^a   Dannenberg, F ^a   Triebe, F ^a   Dirnagl, U ^a   Reuter, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Calcitonin gene related peptide; Migraine; Sumatriptan; Topiramate; Trigeminal activation

Indexed keywords

BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; HISTAMINE; PROSTAGLANDIN E2; SEROTONIN; SUMATRIPTAN; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; JUGULAR VEIN; MIGRAINE; NONHUMAN; RAT; TRIGEMINAL NERVE; VENOUS BLOOD;

ANIMALS; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; DINOPROSTONE; FRUCTOSE; HISTAMINE; HISTAMINE AGONISTS; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPROTECTIVE AGENTS; OXYTOCICS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN AGONISTS; SUMATRIPTAN; TRIGEMINAL NERVE; VASODILATOR AGENTS;

EID: 70349656753     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01858.x     Document Type: Article

References (26)

1. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al. Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med 2004 350 : 1104 1110.
2. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008 70 : 1304 1312.
3. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation in humans during migraine headache. Ann Neurol 1990 28 : 183 187.
4. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993 33 : 48 56.
5. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 2005 58 : 561 568.
6. Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache 2006 46 (Suppl. 1 S3 8.
7. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006 59 : 652 661.
8. Storer RJ, Goadsby PJ. Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia 2004 24 : 1049 1056.
9. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain 2005 128 : 86 97.
10. Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci 2006 27 : 410 415.
11. Calabresi P, Galletti F, Rossi C, Sarchielli P, Cupini LM. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol Sci 2007 28 : 188 195.
12. Durham PL, Niemann C, Cady R. Repression of stimulated calcitonin gene-related peptide secretion by topiramate. Headache 2006 46 : 1291 1295.
13. Burstein R, Yamamura H, Malick M, Strassman AM. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 1998 79 : 964 982.
14. Levy D, Burstein R, Strassman A. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 2005 58 : 698 705.
15. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004 55 : 27 36.
16. Zagami AS, Goadsby PJ, Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990 16 : 69 75.
17. Limmroth V, Katsarava Z, Liedert B, Guehring H, Schmitz K, Diener HC, Michel MC. An in vivo rat model to study calcitonin gene-related peptide release following activation of the trigeminal vascular system. Pain 2001 92 : 101 106.
18. Reuter U, Sanchez del Rio M, Moskowitz MA. Experimental models of migraine. Funct Neurol 2000 15 (Suppl. 3 9 18.
19. Dux M, Sántha P, Jancsó G. Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J Physiol 2003 552 (Pt 3 859 867.
20. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002 22 : 54 61.
21. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004 142 : 1171 1181.
22. Fischer MJ, Koulchitsky S, Messlinger K. The non-peptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 2005 25 : 5877 5883.
23. Zimmermann K, Reeh PW, Averbeck B. S+-flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater. Pain 2003 103 : 313 320.
24. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996 384 : 560 564.
25. Akerman S, Goadsby PJ. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 2005 16 : 1383 1387.
26. Akerman S, Williamson DJ, Goadsby PJ. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol 2003 140 : 558 566.